Switching viral latency to viral lysis: A novel therapeutic approach for Epstein-Barr virus-associated neoplasia

Cancer Research

Volumn 56, Issue 5, 1996, Pages 969-972

  Gutiérrez, Marina I ^a   Judde, Jean Gabriel ^a   Magrath, Ian T ^a   Bhatia, Kishor G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL ACTIVITY; ARTICLE; BREAST CARCINOMA; CELL DEATH; EPSTEIN BARR VIRUS; HODGKIN DISEASE; NASOPHARYNX CARCINOMA; NOSE CANCER; PRIORITY JOURNAL; T CELL LYMPHOMA; VIRION; VIRUS CARCINOGENESIS; VIRUS LATENCY;

ANTIGENS, VIRAL; BASE SEQUENCE; CELL DEATH; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; TRANS-ACTIVATION (GENETICS); TRANSFECTION; VIRUS LATENCY;

EID: 0030067422     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rogers, R., Strominger, P J , and Speck, S. Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency Adv. Cancer Res , 55: 1-26, 1992.
2. Shiramizu, B., Barriga, F , Neequaye, J., Jafri, A., Dalla-Favera, R., Neri, A., Gutierrez, M., Levine, P., and Magrath, I. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood, 77: 1516-1526, 1991.
3. Brousset, P., Knecht, H., Rubin, B., Drouet, E., Chittal, S., Meggetto, F., Al Saati, T., Bachmann, E., Denoyel, G., Sergeant, A., and Delsol, G. Demonstration of Epstein-Barr virus replication in Reed-Stenberg cells of Hodgkin's disease. Blood, 82: 872-876, 1993.
4. Guerrero, I., Franklin, J., Naresh, K. N., Caceres, E., Bhatia, K., O'Conor, G., and Magrath, I. p53 expression, bcl-2 expression and EBV association in Peruvian nasal lymphomas. Blood, 84 (Suppl.). 522a, 1994.
5. Chang, Y. S., Tyan, Y. S., Liu, S. T., Tsai, M. S., and Pao, C. C Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplication. J. Clin. Microbiol., 28. 2398-2402, 1990.
6. Suzushima, H., Asou, N., Fujimoto, T., Nishimura, S , Okubo, T , Yamasaki, H , Osato, M , Matsuoka, M., Tsukamoto, A., Takai, K., et al. Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. Blood, 85: 480-486, 1995.
7. Labrecque, L G , Barnes, D. M., Fentiman, I. S., and Griffin, B. E. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res., 55: 49-45, 1995.
8. Reisman, D., and Sugden, B. Trans-activation of an Epstein-Barr transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1 Mol. Cell Biol., 6: 3828-3846, 1986.
9. Reisman, D., Yates, J., and Sugden, B. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol. Cell Biol., 5. 1822-1832, 1985.
10. Wysokenski, D. A., and Yates, J. L. Multiple EBNA 1-binding sites are required to form an EBNA 1-dependent enhancer and to activate a minimal replicative origin with onP of Epstein-Barr virus J. Virol , 63: 2657-2666, 1989
11. Judde, J. G , Spangler, G , Magrath, I., and Bhatia, K. Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV associated neoplasia. Hum. Gene Ther., in press, 1996.
12. Kieff, E. and Liebowitz, D. Epstein-Barr virus and its replication. In. B. N. Fields, D. M. Knipe, et al Fundamental Virology, 2nd ed. New York: Raven Press, Ltd., 1991.
13. Holley-Guthrie, E. A., Quinlivan, E. B., Mar, E. C., and Kenney, S. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators. BRLF1 and BZLF1, in a cell-specific manner. J. Virol., 64: 3753-3759, 1990.
14. Rooney, C. M., Rowe, D. T., Ragot, T., and Farrell, P. J. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J. Virol., 53: 3109-3116, 1989.
15. Raab-Traub, N., and Flynn, K. The structure of the termini of Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 47: 883-889, 1986.
16. Mizushima, S , and Nagata, S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res., 18: 5322, 1990.
17. Wagstaff, A. J., Faulds, D., and Goa, K. L. Acyclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 47. 153-205, 1994.
18. Gutierrez, M. I., Bhatia, K., and Magrath, I. Replicative viral DNA in Epstein-Barr virus associated Burkina's lymphoma biopsies. Leuk. Res., 17: 285-289, 1993.
19. McKinnell, R G., Ellis, V. L , Dapkus, D. C., and Steven, L. M., Jr. Early replication of herpesviruses in naturally occurring frog tumors. Cancer Res., 32: 1729-1733, 1972.
20. Wagner, H. J., Bein, G. Bitsch, A., and Kirchner, H. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J. Clin. Microbiol., 30: 2826-2829, 1992.